Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1998 1
1999 2
2000 2
2001 4
2002 6
2003 6
2004 10
2005 6
2006 8
2007 13
2008 5
2009 2
2010 1
2011 6
2012 9
2013 4
2014 5
2015 5
2016 7
2017 6
2018 5
2019 12
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 17823140

119 results
Results by year
Filters applied: . Clear all
Page 1
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
Zarychanski R, Turgeon AF, McIntyre L, Fergusson DA. Zarychanski R, et al. CMAJ. 2007 Sep 25;177(7):725-34. doi: 10.1503/cmaj.071055. Epub 2007 Sep 5. CMAJ. 2007. PMID: 17823140 Free PMC article.
Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL. Silver M, et al. Crit Care Med. 2006 Sep;34(9):2310-6. doi: 10.1097/01.CCM.0000233873.17954.42. Crit Care Med. 2006. PMID: 16878035 Clinical Trial.
Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T; EPO Critical Care Trials Group. Corwin HL, et al. JAMA. 2002 Dec 11;288(22):2827-35. doi: 10.1001/jama.288.22.2827. JAMA. 2002. PMID: 12472324 Clinical Trial.
Erythropoietic agents for anemia of critical illness.
Shermock KM, Horn E, Rice TL. Shermock KM, et al. Am J Health Syst Pharm. 2008 Mar 15;65(6):540-6. doi: 10.2146/ajhp070225. Am J Health Syst Pharm. 2008. PMID: 18319499 Review.
Is there a place for epoetin alfa in managing anemia during critical illness?
Givens M, Lapointe M. Givens M, et al. Clin Ther. 2004 Jun;26(6):819-29. doi: 10.1016/s0149-2918(04)90126-9. Clin Ther. 2004. PMID: 15262453 Review.
A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc. Brophy GM, et al. Clin Ther. 2008 Dec;30(12):2324-34. doi: 10.1016/j.clinthera.2008.12.024. Clin Ther. 2008. PMID: 19167591
Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F, Turner AR, Melosky B, Xiu L, Plante RK, Lau CY, Quirt I. Couture F, et al. Oncologist. 2005 Jan;10(1):63-71. doi: 10.1634/theoncologist.10-1-63. Oncologist. 2005. PMID: 15632253 Free article.
Recombinant human erythropoietin use in intensive care.
Darveau M, Notebaert E, Denault AY, Bélisle S. Darveau M, et al. Ann Pharmacother. 2002 Jun;36(6):1068-74. doi: 10.1345/aph.1A323. Ann Pharmacother. 2002. PMID: 12022910 Review.
Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
Ross SD, Allen IE, Henry DH, Seaman C, Sercus B, Goodnough LT. Ross SD, et al. Clin Ther. 2006 Jun;28(6):801-31. doi: 10.1016/j.clinthera.2006.06.003. Clin Ther. 2006. PMID: 16860166 Review.
Use of epoetin alfa in critically ill patients.
Pajoumand M, Erstad BL, Camamo JM. Pajoumand M, et al. Ann Pharmacother. 2004 Apr;38(4):641-8. doi: 10.1345/aph.1D368. Epub 2004 Feb 13. Ann Pharmacother. 2004. PMID: 14966258 Review.
119 results
Jump to page